Patents by Inventor Gillian Morgan

Gillian Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release
    Patent number: 8193168
    Abstract: The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: June 5, 2012
    Assignee: Redpoint Bio Corporation
    Inventors: S. Paul Lee, Peihong Zhou, M. N. Tulu Buber, Rok Cerne, Robert Bryant, F. Raymond Salemme, Gillian Morgan
  • Use of a TRPM5 Inhibitor to Regulate Insulin and GLP-1 Release
    Publication number: 20080306030
    Abstract: The present invention is directed to methods of enhancing insulin release, GLP-1 release, and insulin sensitivity, methods of increasing insulin gene expression, methods of decreasing gastric secretion and emptying and glucagons secretion, and methods of inhibiting food intake, and methods of treating diabetes mellitus, insulin resistance syndrome, hyperglycemia, and obesity comprising administering to a subject an effective amount of a TRPM5 inhibitor.
    Type: Application
    Filed: February 4, 2008
    Publication date: December 11, 2008
    Applicant: Redpoint Bio Corporation
    Inventors: S. Paul Lee, Peihong Zhou, M.N. Tulu Buber, Rok Cerne, Robert Bryant, F. Raymond Salemme, Gillian Morgan